| Literature DB >> 26029869 |
Susanne Kohl1, Ditta Zobor1, Wei-Chieh Chiang2, Nicole Weisschuh1, Jennifer Staller1, Irene Gonzalez Menendez1, Stanley Chang3, Susanne C Beck1, Marina Garcia Garrido1, Vithiyanjali Sothilingam1, Mathias W Seeliger1, Franco Stanzial4, Francesco Benedicenti4, Francesca Inzana4, Elise Héon5, Ajoy Vincent5, Jill Beis6, Tim M Strom7, Günther Rudolph8, Susanne Roosing9, Anneke I den Hollander10, Frans P M Cremers9, Irma Lopez11, Huanan Ren11, Anthony T Moore12, Andrew R Webster13, Michel Michaelides13, Robert K Koenekoop11, Eberhart Zrenner14, Randal J Kaufman15, Stephen H Tsang16, Bernd Wissinger1, Jonathan H Lin17.
Abstract
Achromatopsia (ACHM) is an autosomal recessive disorder characterized by color blindness, photophobia, nystagmus and severely reduced visual acuity. Using homozygosity mapping and whole-exome and candidate gene sequencing, we identified ten families carrying six homozygous and two compound-heterozygous mutations in the ATF6 gene (encoding activating transcription factor 6A), a key regulator of the unfolded protein response (UPR) and cellular endoplasmic reticulum (ER) homeostasis. Patients had evidence of foveal hypoplasia and disruption of the cone photoreceptor layer. The ACHM-associated ATF6 mutations attenuate ATF6 transcriptional activity in response to ER stress. Atf6(-/-) mice have normal retinal morphology and function at a young age but develop rod and cone dysfunction with increasing age. This new ACHM-related gene suggests a crucial and unexpected role for ATF6A in human foveal development and cone function and adds to the list of genes that, despite ubiquitous expression, when mutated can result in an isolated retinal photoreceptor phenotype.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26029869 PMCID: PMC4610820 DOI: 10.1038/ng.3319
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330